40 related articles for article (PubMed ID: 2297495)
1. Circulating Procollagen Type III N-Terminal Peptide and Physical Function in Adults from the Long Life Family Study.
Santanasto AJ; Cvejkus RK; Wojczynski MK; Marron MM; Schupf N; Christensen K; Thyagarajan B; Zmuda JM
J Gerontol A Biol Sci Med Sci; 2021 Jun; 76(7):1273-1279. PubMed ID: 32794566
[TBL] [Abstract][Full Text] [Related]
2. Current issues with procollagen III N-terminal peptide assay performance relevant to 2016 British Association for Dermatologist methotrexate-monitoring guidance.
Taylor DR; Stone C
Clin Exp Dermatol; 2023 Nov; 48(12):1378-1379. PubMed ID: 37616532
[No Abstract] [Full Text] [Related]
3. Blood-based scoring systems for identifying significant liver fibrosis in patients with psoriasis.
Chularojanamontri L; Panjapakkul W; Chaiyabutr C; Pruksaeakanan C; Wongdama S; Likittanasombat S; Bandidniyamanon W; Griffiths CEM; Charatcharoenwitthaya P
Br J Dermatol; 2023 Oct; 189(5):640-641. PubMed ID: 37503679
[No Abstract] [Full Text] [Related]
4. Managing risk of liver fibrosis in psoriatic patients being considered for methotrexate.
Campbell F; Laws P
Br J Dermatol; 2024 Mar; ():. PubMed ID: 38504462
[No Abstract] [Full Text] [Related]
5. Liver fibrosis prevalence and risk factors in patients with psoriasis: A systematic review and meta-analysis.
Yongpisarn T; Namasondhi A; Iamsumang W; Rattanakaemakorn P; Suchonwanit P
Front Med (Lausanne); 2022; 9():1068157. PubMed ID: 36590962
[TBL] [Abstract][Full Text] [Related]
6. Monitoring methotrexate-induced liver fibrosis in patients with psoriasis: utility of transient elastography.
Cheng HS; Rademaker M
Psoriasis (Auckl); 2018; 8():21-29. PubMed ID: 29785393
[TBL] [Abstract][Full Text] [Related]
7. Quantification of liver fibrosis in chronic hepatitis B virus infection.
Jieanu CF; Ungureanu BS; Săndulescu DL; Gheonea IA; Tudorașcu DR; Ciurea ME; Purcărea VL
J Med Life; 2015; 8(3):285-90. PubMed ID: 26351528
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive diagnosis of advanced fibrosis and cirrhosis.
Sharma S; Khalili K; Nguyen GC
World J Gastroenterol; 2014 Dec; 20(45):16820-30. PubMed ID: 25492996
[TBL] [Abstract][Full Text] [Related]
9. Use of amino terminal type III procollagen peptide (P3NP) assay in methotrexate therapy for psoriasis.
Khan S; Subedi D; Chowdhury MM
Postgrad Med J; 2006 May; 82(967):353-4. PubMed ID: 16679477
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of methotrexate in non-neoplastic diseases.
Grim J; Chládek J; Martínková J
Clin Pharmacokinet; 2003; 42(2):139-51. PubMed ID: 12537514
[TBL] [Abstract][Full Text] [Related]
11. Aminoterminal propeptide of type III procollagen in methotrexate-induced liver fibrosis and cirrhosis.
Risteli J; Søgaard H; Oikarinen A; Risteli L; Karvonen J; Zachariae H
Br J Dermatol; 1988 Sep; 119(3):321-5. PubMed ID: 3179204
[TBL] [Abstract][Full Text] [Related]
12. Liver biopsies and methotrexate: a time for reconsideration?
Zachariae H
J Am Acad Dermatol; 2000 Mar; 42(3):531-4. PubMed ID: 10688735
[No Abstract] [Full Text] [Related]
13. Methotrexate for psoriasis in the era of biological therapy.
Warren RB; Chalmers RJ; Griffiths CE; Menter A
Clin Exp Dermatol; 2008 Aug; 33(5):551-4. PubMed ID: 18801095
[TBL] [Abstract][Full Text] [Related]
14. Serum type III procollagen peptide, dynamic liver function tests and hepatic fibrosis in psoriatic patients receiving methotrexate.
Mitchell D; Smith A; Rowan B; Warnes TW; Haboubi NY; Lucas SB; Chalmers RJ
Br J Dermatol; 1990 Jan; 122(1):1-7. PubMed ID: 2297495
[TBL] [Abstract][Full Text] [Related]
15. Abnormalities of serum type III procollagen aminoterminal peptide in methotrexate-treated psoriatic patients with normal liver histology do not correlate with hepatic ultrastructural changes.
Oogarah PK; Rowland PL; Mitchell DM; Smith A; Chalmers RJ; Rowan B; Haboubi NY
Br J Dermatol; 1995 Oct; 133(4):512-8. PubMed ID: 7577576
[TBL] [Abstract][Full Text] [Related]
16. Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: relation to liver fibrosis and arthritis.
Zachariae H; Aslam HM; Bjerring P; Søgaard H; Zachariae E; Heickendorff L
J Am Acad Dermatol; 1991 Jul; 25(1 Pt 1):50-3. PubMed ID: 1880254
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
